Stock Analysis:: Bristol-Myers Squibb Company, (NYSE: BMY)


On Monday, November 16, 2020, the Company, Bristol-Myers Squibb Company, BMY stock construct a change of 1.38 percent (Gain) in a total of its share price and having its trading value $64.5, which belongs to Healthcare sector and Drug Manufacturers – General industry. The company?s Market capitalization was $143.76B with the total Outstanding Shares of 2.26B.


P/S, P/E, P/B & P/C values of (NYSE: BMY):


Bristol-Myers Squibb Company institutional ownership is standing at 75.8 percent, while insider ownership is 0.1 percent. As of now, BMY has a P/S, P/E and, P/B values of 3.65, 0, and 2.9 respectively. Its P/Cash is valued at 6.8.


The stock SMA50 is now at 6.88 percent. In looking, the SMA 200 we see that the stock has seen a 7.53 percent. The Company?s net profit margin for the 12 months at -0.1 percent. Comparatively, the gazes have a Gross margin of 71.5 percent.

Profitability ratios:


Looking into the profitability ratios of BMY stock, an investor will find its ROE, ROA, ROI standing at -0.1 percent, 0 percent and, 5.5 percent, respectively.

Beta Factor:


A beta factor is used to measure the volatility of the stock. The stock remaining at 2.05 percent volatile for the week and 2.26 percent for the month.

Gross / Operating Margins of BMY:


It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 71.5 percent & Operating Margin seen at 8.7 percent.

Target Price:


Target Price informs the inves tors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Bristol-Myers Squibb Company recorded it at $73.18.

Historical Performance In The News:


Taking a look at the performance of Bristol-Myers Squibb Company stock, an investor will come to know that the weekly performance for this stock is valuing at 0.66 percent, resulting in a performance for the month at 5.32 percent.

Therefore, the stated figure displays a quarterly performance of 2.33 percent, bringing six-month performance to 2.85 percent and year to date performance of 0.48 percent. As of now, Bristol-Myers Squibb Company has a P/S, P/E and, P/B values of 3.65, 0, and 2.9 respectively. Its P/Cash is valued at 6.8.

Earnings per Share Details of Bristol-Myers Squibb Company:


The EPS of BMY is strolling at -0.11, measuring its EPS growth this year at -33.9 percent. As a result, the company has an EPS growth of 16.82 percent for the approaching year.